FdaApplication
ANDA 206921
Identifiers
- fda_app_no: ANDA206921
Properties
| Property | Value |
|---|---|
| applicant_name | SANDOZ INC |
| application_type | ANDA |
| approval_date | 2018-02-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GLATOPA | GLATIRAMER ACETATE | 40MG/ML | INJECTABLE;SUBCUTANEOUS |
1 product